Novartis recently received FDA approval to sell a drug aimed at relieving pain for those with sickle cell anemia, and it was first discovered in Oklahoma City.
OMRF is using a four-year, $450,000 grant from the VA's office to try and find a way to make OA medicine safer and more effective for military veterans.